European Journal of Medicinal Chemistry · 2014 · 42 citations · 21 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyMolecular PharmacologySynthetic Medicinal ChemistryCytotoxic ChemotherapyMetabolism Of Anticancer AgentsMtor Inhibitor TherapyPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsAnticancer ActivityAnticancer ChemotherapyBiological Evaluation ReportChemical Synthesis Of AnaloguesMtor InhibitionMtor SignalingPyrimidine AnalogsPyrimidine Analogues
21
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman, Beth Apsel, Aino Uotila et al. · PLoS Biology · 2009 · 1.1K citations · Full text
mTOR kinase structure, mechanism and regulation
Haijuan Yang, Derek G. Rudge, Joseph D. Koos et al. · Nature · 2013 · 1.1K citations
Antonio Monroy‐Noyola, Miguel Á. Sogorb, N. Dı́az-Alejo et al. · Chemico-Biological Interactions · 1999 · 535 citations
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
Matthew R. Janes, Jose J. Limon, Lomon So et al. · Nature Medicine · 2010 · 338 citations · Full text
Medicine, Oncology, Pharmacology +14